News

In a new lawsuit, the U.S. government alleges Novartis paid kickbacks to specialty pharmacies to increase sales of deferasirox (Exjade), which removes excess iron from the blood of patients who receive transfusions, and mycophenolic acid (Myfortic), to prevent rejection of kidney transplants.

The American Society of Clinical Oncology is asking for comments on its ASCO Value Framework, which compares the value of new cancer therapies with established treatments.

Patients with previously-treated metastic colorectal cancer (mCRC) taking regorafenib (Stivarga) experienced progression-free survival of 2.7 months, according to new data presented at the recent ESMO 17th World Congress on Gastrointestinal Cancer 2015 in Barcelona.

A first-in-class antipsychotic that is a selective serotonin inverse agonist (with no dopaminergic, histaminergic, adrenergic, or muscarinic activity) potentially targeting 5-HT2A receptors, improved Parkinson’s disease psychosis (PDP) with demonstrated safety and tolerability, and without worsening motor Parkinson’s, according to data presented in two posters at the 19th International Congress of Parkinson’s Disease and Movement Disorders (MDS), in San Diego.

We are on the verge of healthcare modernization that will transform the healthcare experience.

An active population health management program is key to improving performance, and it needs big data engagement analytics if it’s going to succeed.

According to the August issue of Consumer Reports, the overuse and misuse of antibiotics is leading to the strengthening and spread of dangerous infections that are becoming resistant to these drugs. Here are four recommendations Consumer Reports has for the medical community.

Clearly, healthcare organizations need to be prepared for a cyber breach. The question, then, is: What steps should we take now to prepare?

Healthcare organizations must better incorporate change management and cultural integration into their M&A strategy. Here's how.

FDA has approved Aurobindo’s entacapone tablets USP, 200 mg, the generic equivalent to Novartis’ Comtan tablets 200 mg.

Coverage decisions about new technologies, including access and cost considerations, are a major challenge for public and private payers.

How does your health system compare to others when it comes to new initiatives? Recent survey findings from HFMA might provide some answers.

How do we reverse the trend of super users and reduce costs for this small, unique pool of members? Here are some tips.

Stuart M. Gerson, member of Epstein Becker Green's Litigation and Health Care & Life Sciences practices, discusses four possible consequences of the King v. Burwell ruling.

Health plans, exchanges and associations share their reactions to the Supreme Court's King V. Burwell ruling.

As lipid management in the United States under goes transition in response to new guideline recommendations and expanding lipid-lowering therapy options, the Duke Clinical Research Institute (DCRI) announced a new study to better understand contemporary lipid management as well as the beliefs and attitudes of patient and providers regarding cholesterol, cardiovascular risk assessment, and options for lipid treatments.

While sales of Gilead Science’s popular hepatitis C drug, Harvoni, had been performing well for several months, the trend has reversed of late. Hepatitis C drug Sovaldi, also from Gilead, has also hit some bumps in the road – in both the U.S. and China.

FDA has approved cangrelor (Kengreal, The Medicines Company) for reducing the risk of periprocedural thrombotic events in patients undergoing percutaneous coronary intervention.

Antibiotic resistance is a growing problem, both in the United States and across the world. The main driving factors behind antibiotic resistance are the overuse and misuse of antibiotics, according to the Centers for Disease Control and Prevention.

Here are 5 drug categories that may command the most impact on pharma spending in the near future.

Rep. Steve Stivers (R-Ohio) and Rep. Peter Welch (D-Vt.) have re-introduced the Fair Access for Safe and Timely (FAST) Generics Act to what they say will increase consumer access to generic drugs, boost market competition and ultimately save consumers money.

A new, painless “smart insulin patch” lowered blood glucose in a mouse model of type 1 diabetes for up to 9 hours, according to a study published in the Proceedings of the National Academy of Sciences.

It can be challenging for executives to understand and keep up with rapidly evolving technology terms. Here's help.

Creating buy-in among hospital physicians when embarking on a new technology initiative can be difficult. Here are some tips.

Mobile devices are becoming a very real part of the healthcare journey. Are your physicians making the most of their capabilities?

More adults than children in the United States now take medication for attention deficit hyperactivity disorder (ADHD), according to new data.

Patients to assist insurer, association in creating program to ensure its relevancy and practicality for those with diabetes.

The Institute for Safe Medication Practices (ISMP) is cautioning hospital pharmacists and other healthcare professionals about the intravenous cancer medication fluorouracil.